Ripretinib as second-line treatment for imatinib-resistant advanced gastrointestinal stromal tumors: a case report
@article{GIST104751,
author = {Junzhao You and Nengyi Hou and Song Yu and Jiang Gao and Wei Xie and Xingmei Yuan and Hongtao Tang and Shun Jiang and Minghui Pang},
title = {Ripretinib as second-line treatment for imatinib-resistant advanced gastrointestinal stromal tumors: a case report},
journal = {Gastrointestinal Stromal Tumor},
volume = {8},
number = {0},
year = {2025},
keywords = {},
abstract = {},
issn = {2663-1911}, url = {https://gist.amegroups.org/article/view/104751}
}